Specialized Treatment Early in Psychosis (STEP)

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to understand the effectiveness of a specialized package of phase-specific treatments for individuals in the midst of their first episode of psychosis. The pharmacologic and psychosocial treatments will be delivered within a state public mental health center.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University

Criteria

Inclusion Criteria:

1. Age 16-45

2. Meets DSM-IV schizophrenia spectrum psychosis or affective psychosis according to the SCID

3. ≤8 weeks of received antipsychotic treatment lifetime at time of referral

4. Willing to be treated in New Haven

Exclusion Criteria:

1. Psychosis believed due to substance use (based on the SCID)

2. Unable or unwilling to give informed consent

3. MR as indicated by receipt of services from Dept of Mental Retardation